MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer

NCT03300817 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

NIH

Sponsor class

Conditions

Lung Carcinoma

Interventions

OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: MUC1 Peptide-Poly-ICLC Vaccine

Sponsor

National Cancer Institute (NCI)